EUVIMEDEUVIMED entdecken
Crossref

Immune Cells and Risk of Cervical Cancer: Evidence from a Mendelian Randomization Study

Lin Guo, Xi Yuan, Yun Zhou, Da Zhang, Hui Hui, Yan Zhang

Clinical Laboratory · 2026 · 72 (04/2026)

DOI: 10.7754/clin.lab.2025.250552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Lin Guo und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsMendelian Randomization AnalysisPolymorphism, Single NucleotideHumansFemaleGenetic Predisposition to DiseaseRisk Factors

Zitieren

APA

Guo, L., Yuan, X., Zhou, Y., Zhang, D., Hui, H., & Zhang, Y. (2026). Immune Cells and Risk of Cervical Cancer: Evidence from a Mendelian Randomization Study. Clinical Laboratory, 72(04/2026). https://doi.org/10.7754/clin.lab.2025.250552

Vancouver

Guo L, Yuan X, Zhou Y, Zhang D, Hui H, Zhang Y. Immune Cells and Risk of Cervical Cancer: Evidence from a Mendelian Randomization Study. Clinical Laboratory. 2026;72(04/2026). doi:10.7754/clin.lab.2025.250552

BibTeX
@article{Guo2026,
  author = {Guo, Lin and Yuan, Xi and Zhou, Yun and Zhang, Da and Hui, Hui and Zhang, Yan},
  title = {Immune Cells and Risk of Cervical Cancer: Evidence from a Mendelian Randomization Study},
  journal = {Clinical Laboratory},
  year = {2026},
  volume = {72},
  number = {04/2026},
  doi = {10.7754/clin.lab.2025.250552}
}
Kostenlos starten →